Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Petoskey, Michigan, United States
Countries of investment
  • USA
  • focusing on Central US
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Medical Devices
  • Health Tech
About
BioStar Ventures is an early-stage life sciences fund investing in therapeutics, diagnostics, and digital health ventures with scientific and entrepreneurship expertise.
Min check size
$100K
Max check size
$38.9M
Fund size
NPS

Investment Thesis

BioStar Ventures focuses on early stage investment in transformational medical technologies. They leverage clinical and business expertise to advance innovations that significantly impact patient care and generate substantial returns for investors.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Backed by a robust portfolio, the fund manager has executed over 50 investments across North America and Europe, with a focus on technology and healthcare sectors. Having led multiple successful exits, the manager demonstrates a keen ability to identify high-potential opportunities at the early and growth stages. Built a track record of strategic partnerships, their approach combines thorough market analysis with a commitment to long-term value creation. With experience in navigating complex investment landscapes, they adeptly align resources to drive innovation and scale within their portfolio companies.

BioStar Ventures Contacts Information

Primary contact

Secondary contact

Team

Paul Scott

Louis Cannon

Louis Cannon

Renee Masi

Jim Bennethum

Hank Kucheman

Carl Deirmengian

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp